Responses
Other responses
Jump to comment:
- Published on: 9 January 2022
- Published on: 9 January 2022
- Published on: 9 January 2022Re: Need for prospective studiesShow More
The letter from Dr Mantadakis addresses the important issue of the absence of randomised studies on the clinical effectiveness of the interventions used to prevent the possible severe sequelae of fetal alloimmune thrombocytopenia. Studies in small series are suggestive of some benificial effect of the current interventions like high dose intravenous immunoglobulin to the mother or intrauterine transfusion of HPA compat...
Conflict of Interest:
None declared. - Published on: 9 January 2022Need for prospective studiesShow More
This review on alloimmune thrombocytopenic purpura (ATP) by OUWEHAND et al is excellent and describes the current knowledge on ATP. Regarding the management of this condition, since no randomised trials have been performed using IVIg or intravenous corticosteroids during pregnancy, no evidence-based guidelines for the use of either treatment exist. I believe it is necessary for a multi-institutuional trial on the preventio...
Conflict of Interest:
None declared.